Doping control analysis of small peptides: A decade of progress.

[1]  G. N. Leung,et al.  DETECTION OF BIOACTIVE PEPTIDES INCLUDING GONADOTROPHIN-RELEASING FACTORS (GnRHs) IN HORSE URINE USING ULTRA-HIGH PERFORMANCE LIQUID CHROMATOGRAPHY-HIGH RESOLUTION MASS SPECTROMETRY (UHPLC/HRMS). , 2020, Drug testing and analysis.

[2]  M. Thevis,et al.  Fully automated dried blood spot sample preparation enables the detection of lower molecular mass peptide and non-peptide doping agents by means of LC-HRMS , 2020, Analytical and Bioanalytical Chemistry.

[3]  J. Coumbaros,et al.  Dispersive SPE, an alternative to traditional SPE for extraction of 43 doping peptides from equine urine prior to LC–MS screening , 2020, Forensic Toxicology.

[4]  M. Thevis,et al.  Analytical Approaches in Human Sports Drug Testing - Recent Advances, Challenges, and Solutions. , 2020, Analytical Chemistry.

[5]  I. Zamora,et al.  Software-aided workflow for predicting protease-specific cleavage sites using physicochemical properties of the natural and unnatural amino acids in peptide-based drug discovery , 2018, bioRxiv.

[6]  M. Thevis,et al.  Recent improvements in sports drug testing concerning the initial testing for peptidic drugs (< 2 kDa) - sample preparation, mass spectrometric detection, and data review. , 2018, Drug testing and analysis.

[7]  Laura Orsatti,et al.  A liquid chromatography high‐resolution mass spectrometry in vitro assay to assess metabolism at the injection site of subcutaneously administered therapeutic peptides , 2018, Journal of pharmaceutical and biomedical analysis.

[8]  Hong Yang,et al.  Metabolism of Peptide Drugs and Strategies to Improve their Metabolic Stability. , 2018, Current drug metabolism.

[9]  K. Deventer,et al.  Urinary matrix effects in electrospray ionization mass spectrometry in the presence of DMSO. , 2018, Journal of mass spectrometry : JMS.

[10]  M. Popławska,et al.  Identification of a novel growth hormone releasing peptide (a glycine analogue of GHRP-2) in a seized injection vial. , 2018, Drug testing and analysis.

[11]  A. Sickmann,et al.  Analysis of new growth promoting black market products. , 2018, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

[12]  L. Pickart,et al.  Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data , 2018, International journal of molecular sciences.

[13]  M. Moon,et al.  Development of a multi-functional concurrent assay using weak cation-exchange solid-phase extraction (WCX-SPE) and reconstitution with a diluted sample aliquot for anti-doping analysis. , 2018, Rapid communications in mass spectrometry : RCM.

[14]  K. Deventer,et al.  Comprehensive analysis by liquid chromatography Q-Orbitrap mass spectrometry: Fast screening of peptides and organic molecules. , 2018, Journal of mass spectrometry : JMS.

[15]  J. Loo,et al.  Enhancing Sensitivity of Liquid Chromatography-Mass Spectrometry of Peptides and Proteins Using Supercharging Agents. , 2017, International journal of mass spectrometry.

[16]  M. Fernández-Álvarez,et al.  Determination of doping peptides via solid-phase microelution and accurate-mass quadrupole time-of-flight LC-MS. , 2017, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[17]  D. Eichner,et al.  Detection and in vitro metabolism of the confiscated peptides BPC 157 and MGF R23H. , 2017, Drug testing and analysis.

[18]  M. Thevis,et al.  Characterization of in vitro generated metabolites of selected peptides <2 kDa prohibited in sports. , 2017, Drug testing and analysis.

[19]  Jolene L. Lau,et al.  Therapeutic peptides: Historical perspectives, current development trends, and future directions. , 2017, Bioorganic & medicinal chemistry.

[20]  P. J. Pedersen,et al.  Absorption, metabolism and excretion of the GLP‐1 analogue semaglutide in humans and nonclinical species , 2017, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[21]  R. Hoffmann,et al.  Differential stability of therapeutic peptides with different proteolytic cleavage sites in blood, plasma and serum , 2017, PloS one.

[22]  K. Deventer,et al.  DMSO Assisted Electrospray Ionization for the Detection of Small Peptide Hormones in Urine by Dilute-and-Shoot-Liquid-Chromatography-High Resolution Mass Spectrometry , 2017, Journal of The American Society for Mass Spectrometry.

[23]  A. Sanchez,et al.  Bioactive peptides: A review , 2017 .

[24]  J. Segura,et al.  Detection of Growth Hormone Releasing Peptides in Serum by aCompetitive Receptor Binding Assay , 2017 .

[25]  M. Thevis,et al.  Simplifying and expanding analytical capabilities for various classes of doping agents by means of direct urine injection high performance liquid chromatography high resolution/high accuracy mass spectrometry. , 2016, Journal of pharmaceutical and biomedical analysis.

[26]  G. Rodchenkov,et al.  Comparison of various in vitro model systems of the metabolism of synthetic doping peptides: Proteolytic enzymes, human blood serum, liver and kidney microsomes and liver S9 fraction. , 2016, Journal of proteomics.

[27]  G. Rodchenkov,et al.  Solid-phase extraction of small biologically active peptides on cartridges and microelution 96-well plates from human urine. , 2016, Drug testing and analysis.

[28]  P. Heining,et al.  The Use of Minipig in Drug Discovery and Development , 2016, Toxicologic pathology.

[29]  J. Veuthey,et al.  Analytical Strategies for Doping Control Purposes: Needs, Challenges, and Perspectives. , 2016, Analytical chemistry.

[30]  L. Khawli,et al.  Key factors influencing ADME properties of therapeutic proteins: A need for ADME characterization in drug discovery and development , 2015, mAbs.

[31]  M. Thevis,et al.  Determination of growth hormone releasing peptides metabolites in human urine after nasal administration of GHRP-1, GHRP-2, GHRP-6, Hexarelin, and Ipamorelin. , 2015, Drug testing and analysis.

[32]  M. Farré,et al.  Fit-for-Purpose Radio Receptor Assay for the Determination of Growth Hormone Secretagogues in Urine , 2015, Journal of biomolecular screening.

[33]  F. Botrè,et al.  Development and validation of a liquid chromatography–mass spectrometry procedure after solid-phase extraction for detection of 19 doping peptides in human urine , 2015, Forensic Toxicology.

[34]  A. Nongonierma,et al.  Improved short peptide identification using HILIC-MS/MS: retention time prediction model based on the impact of amino acid position in the peptide sequence. , 2015, Food chemistry.

[35]  Joël Richard,et al.  Challenges in the delivery of peptide drugs: an industry perspective. , 2015, Therapeutic delivery.

[36]  K. Deventer,et al.  In vitro models for metabolic studies of small peptide hormones in sport drug testing , 2015, Journal of peptide science : an official publication of the European Peptide Society.

[37]  A. Elaissari,et al.  Administration strategies for proteins and peptides. , 2014, International journal of pharmaceutics.

[38]  Wilhelm Schänzer,et al.  Detecting peptidic drugs, drug candidates and analogs in sports doping: current status and future directions , 2014, Expert review of proteomics.

[39]  J. Vine,et al.  A high-throughput LC-MS/MS screen for GHRP in equine and human urine, featuring peptide derivatization for improved chromatography. , 2014, Drug testing and analysis.

[40]  J. Vine,et al.  A high throughput screen for 17 Dermorphin peptides in equine and human urine and equine plasma. , 2014, Drug testing and analysis.

[41]  A. Beck‐Sickinger,et al.  Automated solid-phase peptide synthesis to obtain therapeutic peptides , 2014, Beilstein journal of organic chemistry.

[42]  David Handelsman,et al.  Detection and effects on serum and urine steroid and LH of repeated GnRH analog (leuprolide) stimulation , 2014, The Journal of Steroid Biochemistry and Molecular Biology.

[43]  M. Sarwal,et al.  Optimization for peptide sample preparation for urine peptidomics , 2014, Clinical Proteomics.

[44]  Nageswara Rao Pilli,et al.  Highly sensitive assay for the determination of therapeutic peptide desmopressin in human plasma by UPLC–MS/MS☆ , 2013, Journal of pharmaceutical analysis.

[45]  Bernhard Kuster,et al.  DMSO enhances electrospray response, boosting sensitivity of proteomic experiments , 2013, Nature Methods.

[46]  G. N. Leung,et al.  Doping control analysis of seven bioactive peptides in horse plasma by liquid chromatography–mass spectrometry , 2013, Analytical and Bioanalytical Chemistry.

[47]  D. Craik,et al.  The Future of Peptide‐based Drugs , 2013, Chemical biology & drug design.

[48]  T. Wan,et al.  Doping control analysis of TB-500, a synthetic version of an active region of thymosin β₄, in equine urine and plasma by liquid chromatography-mass spectrometry. , 2012, Journal of chromatography. A.

[49]  M. Thevis,et al.  Metabolism of growth hormone releasing peptides. , 2012, Analytical chemistry.

[50]  M. Thevis,et al.  Determination of prohibited, small peptides in urine for sports drug testing by means of nano-liquid chromatography/benchtop quadrupole orbitrap tandem-mass spectrometry. , 2012, Journal of chromatography. A.

[51]  K. Deventer,et al.  Synthesis and characterization of the N-terminal acetylated 17-23 fragment of thymosin beta 4 identified in TB-500, a product suspected to possess doping potential. , 2012, Drug testing and analysis.

[52]  Stephanie Smith,et al.  Small Signaling Peptides in Arabidopsis Development: How Cells Communicate Over a Short Distance , 2012, Plant Cell.

[53]  M. Thevis,et al.  Analytical challenges in the detection of peptide hormones for anti-doping purposes. , 2012, Bioanalysis.

[54]  Xinmiao Liang,et al.  Two-dimensional liquid chromatography separation of peptides using reversed-phase/weak cation-exchange mixed-mode column in first dimension. , 2012, Journal of chromatography. A.

[55]  M. Meyer,et al.  Current applications of high-resolution mass spectrometry in drug metabolism studies , 2012, Analytical and Bioanalytical Chemistry.

[56]  K. Deventer,et al.  Qualitative detection of desmopressin in plasma by liquid chromatography–tandem mass spectrometry , 2012, Analytical and Bioanalytical Chemistry.

[57]  Ilkka Ojanperä,et al.  Current use of high-resolution mass spectrometry in drug screening relevant to clinical and forensic toxicology and doping control , 2012, Analytical and Bioanalytical Chemistry.

[58]  Wilhelm Schänzer,et al.  Doping control analysis of selected peptide hormones using LC-MS(/MS). , 2011, Forensic science international.

[59]  M. Thevis,et al.  Determination of growth hormone releasing peptides (GHRP) and their major metabolites in human urine for doping controls by means of liquid chromatography mass spectrometry , 2011, Analytical and bioanalytical chemistry.

[60]  M. Zdravkovic,et al.  Metabolism and Excretion of the Once-Daily Human Glucagon-Like Peptide-1 Analog Liraglutide in Healthy Male Subjects and Its In Vitro Degradation by Dipeptidyl Peptidase IV and Neutral Endopeptidase , 2010, Drug Metabolism and Disposition.

[61]  S. Kageyama,et al.  Influence of intravenous administration of growth hormone releasing peptide-2 (GHRP-2) on detection of growth hormone doping: growth hormone isoform profiles in Japanese male subjects. , 2010, Drug testing and analysis.

[62]  I. Marc,et al.  Modeling the separation of small peptides by cation-exchange chromatography. , 2010, Journal of separation science.

[63]  S. Kageyama,et al.  Determination of growth hormone secretagogue pralmorelin (GHRP-2) and its metabolite in human urine by liquid chromatography/electrospray ionization tandem mass spectrometry. , 2010, Rapid communications in mass spectrometry : RCM.

[64]  Jiunn H Lin,et al.  Pharmacokinetics of biotech drugs: peptides, proteins and monoclonal antibodies. , 2009, Current drug metabolism.

[65]  M. Thevis,et al.  Mass spectrometric determination of gonadotrophin-releasing hormone (GnRH) in human urine for doping control purposes by means of LC-ESI-MS/MS. , 2008, Journal of mass spectrometry : JMS.

[66]  E. Bardaji,et al.  Synthetic Antimicrobial Peptides as Agricultural Pesticides for Plant‐Disease Control , 2008, Chemistry & biodiversity.

[67]  G. Merriam,et al.  Growth hormone (GH)–releasing hormone and GH secretagogues in normal aging: Fountain of Youth or Pool of Tantalus? , 2008, Clinical interventions in aging.

[68]  M. Thevis,et al.  Emerging drugs--potential for misuse in sport and doping control detection strategies. , 2007, Mini reviews in medicinal chemistry.

[69]  Wilhelm Schänzer,et al.  Current role of LC-MS(/MS) in doping control , 2007, Analytical and bioanalytical chemistry.

[70]  D. Armstrong,et al.  Analysis of native amino acid and peptide enantiomers by high-performance liquid chromatography/atmospheric pressure chemical ionization mass spectrometry. , 2004, Journal of mass spectrometry : JMS.

[71]  G. Irvine.  High-performance size-exclusion chromatography of peptides. , 2003, Journal of biochemical and biophysical methods.

[72]  C. Rehfeldt,et al.  Gonadotropin release in periovulatory heifers after GnRH analogs measured by two types of immunoassays. , 2002, Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association.

[73]  V. D. Hoang,et al.  Characterization of human nasal primary culture systems to investigate peptide metabolism. , 2002, International journal of pharmaceutics.

[74]  E. Williams,et al.  Effects of solvent on the maximum charge state and charge state distribution of protein ions produced by electrospray ionization , 2000, Journal of the American Society for Mass Spectrometry.

[75]  M. Hennion.  Solid-phase extraction: method development, sorbents, and coupling with liquid chromatography. , 1999, Journal of chromatography. A.

[76]  B. Rode,et al.  Peptides and the origin of life1 , 1999, Peptides.

[77]  Mario Thevis,et al.  Recent advances in the determination of insulins from biological fluids. , 2019, Advances in clinical chemistry.

[78]  D. Jaradat.  Thirteen decades of peptide synthesis: key developments in solid phase peptide synthesis and amide bond formation utilized in peptide ligation , 2017, Amino Acids.

[79]  J. Segura,et al.  Structure-activity relationship for peptídic growth hormone secretagogues. , 2017, Drug testing and analysis.

[80]  I. Zvereva,et al.  Determination of GnRH and its synthetic analogues' abuse in doping control: Small bioactive peptide UPLC-MS/MS method extension by addition of in vitro and in vivo metabolism data; evaluation of LH and steroid profile parameter fluctuations as suitable biomarkers. , 2018, Drug testing and analysis.

[81]  M. Thevis,et al.  Simplifying and expanding the screening for peptides <2 kDa by direct urine injection, liquid chromatography, and ion mobility mass spectrometry. , 2016, Journal of separation science.

[82]  D. Eichner,et al.  Detection and in vitro metabolism of AOD9604. , 2015, Drug testing and analysis.

[83]  Li Di,et al.  Strategic Approaches to Optimizing Peptide ADME Properties , 2014, The AAPS Journal.

[84]  P. Varamini,et al.  Gonadotropin Releasing Hormone , 2014 .

[85]  Ó. Pozo,et al.  Analytical strategies based on mass spectrometric techniques for the study of steroid metabolism , 2014 .

[86]  T. Katsila,et al.  Peptide and protein drugs: the study of their metabolism and catabolism by mass spectrometry. , 2012, Mass spectrometry reviews.

[87]  J. Segura,et al.  Growth hormone secretagogues: out of competition , 2011, Analytical and Bioanalytical Chemistry.

[88]  Atsushi. Tsukamoto,et al.  Rapid peptide separation by supercritical fluid chromatography. , 2010, Bioanalysis.

[89]  J. Boyle.  Lehninger principles of biochemistry (4th ed.): Nelson, D., and Cox, M. , 2005 .

[90]  D. Le Roith,et al.  Control of growth by the somatropic axis: growth hormone and the insulin-like growth factors have related and independent roles. , 2001, Annual review of physiology.